|
注册号: Registration number: |
ChiCTR2600126551 |
|
最近更新日期: Date of Last Refreshed on: |
2026-06-11 09:38:02 |
|
注册时间: Date of Registration: |
2026-06-11 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
黏性骨应用下颌阻生第三磨牙拔除后相邻第二磨牙远中牙槽骨缺损修复的临床效果评价 |
|
Public title: |
Clinical Evaluation of the Efficacy of Sticky Bone in the Repair of Distal Alveolar Bone Defects of the Adjacent Second Molar Following Mandibular Impacted Third Molar Extraction |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
黏性骨应用下颌阻生第三磨牙拔除后相邻第二磨牙远中牙槽骨缺损修复的临床效果评价 |
|
Scientific title: |
Clinical Evaluation of the Efficacy of Sticky Bone in the Repair of Distal Alveolar Bone Defects of the Adjacent Second Molar Following Mandibular Impacted Third Molar Extraction |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
高岩翔 |
研究负责人: |
宫坤 |
|
Applicant: |
Gao Yanxiang |
Study leader: |
Gong Kun |
|
申请注册联系人电话: Applicant telephone: |
+86 195 5896 8215 |
研究负责人电话:
Study leader's |
+86 186 1507 7265 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
g1351650616@163.com |
研究负责人电子邮件: Study leader's E-mail: |
gklyfe@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
烟台市口腔医院 |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
|
|
申请注册联系人通讯地址: |
中国山东省烟台市莱山区逛荡河东路1866号 |
研究负责人通讯地址: |
中国山东省烟台市莱山区逛荡河东路1866号 |
|
Applicant address: |
No. 1866, Guangdanghe East Road, Laishan District, Yantai City, Shandong Province, China |
Study leader's address: |
No. 1866, Guangdanghe East Road, Laishan District, Yantai City, Shandong Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
264003 |
研究负责人邮政编码: Study leader's postcode: |
264003 |
|
申请人所在单位: |
山东医药大学口腔医院·烟台市口腔医院 |
||
|
Applicant's institution: |
Stomatological Hospital Shandong Medical and Pharmaceutical University,Yantai stomatological hospital ,Yantai, China |
||
|
研究负责人所在单位: |
山东医药大学口腔医院·烟台市口腔医院 |
||
|
Affiliation of the Leader: |
Stomatological Hospital Shandong Medical and Pharmaceutical University,Yantai stomatological hospital ,Yantai, China |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
202602001 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
烟台市口腔医院伦理委员会 |
||
|
Name of the ethic committee: |
Yantai Stomatological Hospital Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2026-02-01 00:00:00 | ||
|
伦理委员会联系人: |
任静宜 |
||
|
Contact Name of the ethic committee: |
Ren Jingyi |
||
|
伦理委员会联系地址: |
中国山东省烟台市莱山区逛荡河东路1866号 |
||
|
Contact Address of the ethic committee: |
No. 1866, Guangdanghe East Road, Laishan District, Yantai City, Shandong Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 535 602 0160 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
烟台市口腔医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Yantai Stomatological Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国山东省烟台市莱山区逛荡河东路1866号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 1866, Guangdanghe East Road, Laishan District, Yantai City, Shandong Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
医院资助 |
||||||||||||||||||||||
|
Source(s) of funding: |
Hospital Funding |
||||||||||||||||||||||
|
研究疾病: |
下颌第三磨牙拔除后第二磨牙远中骨缺损 |
||||||||||||||||||||||
|
Target disease: |
Distal Bone Defect of the Second Molar Following Mandibular Third Molar Extraction |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究拟通过随机对照研究,研究黏性骨在第三磨牙拔除后第二磨牙远中骨缺损修复中的效果,以牙周检查、影像学骨密度、患者术后反应为核心测量指标,为临床决策提供循证依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study aims to evaluate the efficacy of sticky bone in the repair of distal bone defects of the adjacent second molar following mandibular third molar extraction through a randomized controlled trial. The core outcome measures will include periodontal examination, radiographic bone density, and patient-reported postoperative responses, in order to provide an evidence-based foundation for clinical decision-making. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.有全身系统性疾病 2.对手术中使用的任何药物或植骨材料过敏 3.酗酒或大量吸烟(>10支/天) 4.头颈部放射治疗史 5.严重颞下颌关节紊乱综合征 6.第二磨牙缺失或连同第三磨牙一起拔除 7.研究期间进行正畸的患者 8.女性月经期或妊娠期 9.第三磨牙有囊肿或囊性改变或存在急性炎症 10.不能配合随访及半年之内参加其他研究者 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Presence of any systemic disease. 2. Allergy to any medication or bone graft material used in the surgery. 3. Alcohol abuse or heavy smoking (>10 cigarettes/day). 4. History of head and neck radiotherapy. 5. Severe temporomandibular joint disorders. 6. Absence of the second molar or its extraction along with the third molar. 7. Patients undergoing orthodontic treatment during the study period. 8. Female patients during menstruation or pregnancy. 9. Presence of a cyst, cystic change, or acute inflammation associated with the third molar. 10. Inability to cooperate with follow-up or participation in another clinical study within the past six months. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-05-01 00:00:00至 To 2027-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-06-15 00:00:00 至 To 2027-06-15 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
本研究采用区组随机法。由不参与临床手术及评估的独立第三方统计员,利用计算机统计软件生成随机序列及对应的分组代码。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
This study adopts block randomization. An independent third-party statistician, who is not involved in the clinical surgery or assessment, generates the random sequence and corresponding group codes using computer statistical software. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
本研究采用双盲设计。为实施盲法,干预措施(实验组与对照组所用材料)由不参与研究的药剂师/技术人员根据随机分组代码提前准备,确保其外观、包装、使用方法(如注射器规格、操作步骤)完全一致。所有材料以相同编号的密封套件形式提供。研究过程中,受试者、负责手术的外科医生、术后评估的检查者及数据分析师均对分组不知情。仅不参与临床流程的统计员持有盲底。仅在发生严重不良事件且必须知晓干预内容以进行医疗处理时,方可由主要研究者申请紧急揭盲,并详细记录原因。整个研究的数据录入与初步分析均在盲态下完成。 |
|
Blinding: |
Concealed Allocation Method: A computer-generated block randomization sequence is maintained by an independent third-party statistician not involved in recruitment, surgery, or assessment. After eligible participants complete the baseline assessment, the investigator contacts this statistician via telephone or an online system. The statistician provides a unique group code in real-time based on the pre-generated sequence, and the investigator executes the corresponding protocol accordingly. The allocation information is kept confidential from the investigators, participants, and assessors throughout the study. |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
论文 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
paper |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表;电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Report Form;Electronic Data Capture (and Management) System |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |